Indaptus Therapeutics, Inc.
8-K
March 24, 2026
Key Highlights
- New investor group led by Yun Yao secures 96.4% voting control
- Complete board reconstitution and leadership overhaul
- Strategic pivot toward cash preservation and potential partnership models
Read Analysis
🤖 AI Generated